Senesce to Survive: YAP-Mediated Dormancy Escapes EGFR/MEK Inhibition

Igor Bado, Xiang H.F. Zhang

Research output: Contribution to journalComment/debate

5 Scopus citations


Therapeutic resistance is a major challenge in cancer treatment. In this issue of Cancer Cell, Kurppa et al. demonstrated that a senescence-like state enables lung cancer cells to survive dual inhibition of EGFR and MEK. This was mediated by the YAP/TEAD pathway, which drives epigenomic reprogramming and EMT to counteract apoptosis.

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalCancer Cell
Issue number1
StatePublished - 13 Jan 2020
Externally publishedYes


Dive into the research topics of 'Senesce to Survive: YAP-Mediated Dormancy Escapes EGFR/MEK Inhibition'. Together they form a unique fingerprint.

Cite this